Luke Chen, MD, PhD, Glaxo Distinguished Professor, Biological and Biomedical Sciences, Cancer Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University. Chen's lab is primarily interested in developing targeted therapy for esophageal squamous cell carcinoma. They are also interested in GERD, Barrett's esophagus and alcohol-associated esophageal diseases.

Ashley Leak Bryant, PhD, RN-BC, OCN, FAAN. This lecture will offer free CNE, ACPE and ASRT continuing education credits.

The NCI-funded Geographic Management of Cancer Health Disparities Program (GMaP) Region 1-South (NC, SC, TN) will host a half day virtual symposium. The purpose of the symposia is to disseminate information about ongoing research in cancer health disparities in Region 1-South and to identify ways that members in this region can collaborate, to promote cancer … Read more